Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec;4(24):479.
doi: 10.21037/atm.2016.12.52.

Effects of curcumin on Helicobacter pylori infection

Affiliations

Effects of curcumin on Helicobacter pylori infection

Vaclav Vetvicka et al. Ann Transl Med. 2016 Dec.

Erratum in

Abstract

Background: Curcumin is a well-established natural molecule with significant biological and pharmaceutical effects. Its effects on Helicobacter pylori (H. pylori) infection have been repeatedly confirmed both in animal and human models. This study directly compared five different samples to evaluate if the effects are general or if they differ among samples.

Methods: Using a mouse model, we studied the effects of curcumin on lipid peroxide (LPO) level, myeloperoxidase (MPO) and urease activity, number of colonized bacteria, levels of anti-H. pylori antibodies, biofilm formation, IFN-γ, IL-4, gastrin and somatostatin levels in serum, and minimum inhibitory concentration. In addition, we evaluated the effects on biofilm production and antibacterial antibody response.

Results: In all tests, one sample (Sabinsa) was consistently the most active.

Conclusions: All curcumin samples showed some anti-H. pylori effects, but only some of the tested samples had significant activity.

Keywords: Biofilm; Helicobacter pylori (H. pylori); curcumin.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Effects of curcumin on serum levels of IL-4. Results represent mean from three experiments ± SD. *, represents significant differences between the control and curcumin-treated mice at P≤0.05 level.
Figure 2
Figure 2
Effects of curcumin on serum levels of IFN-γ. Results represent mean from three experiments ± SD. *, represents significant differences between the control and curcumin-treated mice at P≤0.05 level.
Figure 3
Figure 3
Effects of curcumin on serum levels of somatostatin. Results represent mean from three experiments ± SD. *, represents significant differences between the control and curcumin-treated mice at P≤0.05 level.
Figure 4
Figure 4
Effects of curcumin on serum levels of gastrin. Results represent mean from three experiments ± SD. *, represents significant differences between the control and curcumin-treated mice at P≤0.05 level.
Figure 5
Figure 5
Effects of curcumin on LPO abundance in gastric mucosal tissue. Results represent mean from three experiments ± SD. *, represents significant differences between the control and curcumin-treated mice at P≤0.05 level. LPO, lipid peroxide.
Figure 6
Figure 6
Effects of curcumin on MPO activity in gastric mucosal tissue. Results represent mean from three experiments ± SD. *, represents significant differences between the control and curcumin-treated mice at P≤0.05 level. MPO, myeloperoxidase.
Figure 7
Figure 7
Effects of curcumin on anti-H. pylori IgG formation. Results represent mean from three experiments ± SD. *, represents significant differences between the control and curcumin-treated mice at P≤0.05 level. H. pylori, Helicobacter pylori.

References

    1. Parsonnet J. Bacterial infection as a cause of cancer. Environ Health Perspect 1995;103 Suppl 8:263-8. 10.1289/ehp.95103s8263 - DOI - PMC - PubMed
    1. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992;102:493-6. 10.1016/0016-5085(92)90095-G - DOI - PubMed
    1. García A, Salas-Jara MJ, Herrera C, et al. Biofilm and Helicobacter pylori: from environment to human host. World J Gastroenterol 2014;20:5632-8. 10.3748/wjg.v20.i19.5632 - DOI - PMC - PubMed
    1. Richter J, Vetvicka V, Kral V, et al. Helicobacter infection and allergy in majority and Roma population in the Czech Republic. Am J Immunol 2014;10:166-72. 10.3844/ajisp.2014.166.172 - DOI
    1. Zaidi SF, Muhammad JS, Usmanghani K, et al. Review: Pharmacological ins and outs of medicinal plants against Helicobacter pylori: A review. Pak J Pharm Sci 2015;28:1171-6. - PubMed